The China National Medical Products Administration has approved BAT1406. 

Congratulations to Bio-Thera as the first adalimumab biosimilar has been approved by the NMPA in China!
Texcell is proud to have contributed to this success with the viral safety performed in France.

Leave a Reply

You must be logged in to post a comment.